Anticonvulsant Activity of Naringenin in Wistar Rats: Reduction in Inflammation Biomarkers
Applied Sciences · 19.05.2026 · 16 (10) · 5057
DOI: 10.3390/app16105057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 19.05.2026. Verfasst von Isaac Zamora-Bello und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Group of Biology, Chemistry, and Molecular Functionality of Plant Metabolites (UV-CA-368) of the Universidad Veracruzana, Sistema Nacional de Investigadores.
Abstract (Originalsprache)
Introduction
Spontaneous and recurrent epileptic seizures cause neuroinflammation, whereas the chronic administration of antiepileptic drugs may lead to hepatotoxicity and nephrotoxicity. Investigating natural compounds such as naringenin, which exhibits antioxidant, anti-inflammatory, and neuroprotective properties, could mitigate these toxic effects. However, whether naringenin delays seizure onset through anti-inflammatory mechanisms remains unclear.
Objective
We evaluated the anticonvulsant effect of subchronic naringenin administration and its impact on inflammatory biomarkers in rats.
Methods
Thirty-two male Wistar rats were divided into four groups (n = 8 each): vehicle (10% DMSO), naringenin (50 mg/kg), naringenin (100 mg/kg), and diazepam (4 mg/kg). Treatments were administered once daily for ten days through the intraperitoneal route. On day 11, status epilepticus (SE) was induced via the lithium-pilocarpine model. One hour after SE onset, cardiac blood was collected, and the serum was analyzed via ELISA to quantify the following inflammatory markers: superoxide dismutase (SOD), C-reactive protein (CRP), carbonyl protein, and nitrite/nitrate.
Results
We found that 100 mg/kg naringenin increased the latency to SE and the first generalized seizure and shortened the duration of generalized seizures. Fifty percent of the rats in the 100 mg/kg naringenin group did not develop SE. The group treated with 100 mg/kg naringenin demonstrated reduced levels of CRP, protein carbonyls, and nitrates; conversely, the inhibition of SOD activity increased.
Conclusions
Naringenin exerted anticonvulsant activity associated with a reduction in oxidative stress and inflammatory plasma biomarkers, suggesting its potential utility in the future development of alternative treatments to reduce epilepsy symptoms.
Förderung
- Academic Group of Biology, Chemistry, and Molecular Functionality of Plant Metabolites (UV-CA-368) of the Universidad Veracruzana
- Sistema Nacional de Investigadores
Zitieren
APA
Zamora-Bello, I., Rivadeneyra-Domínguez, E., Saldaña-Hoyos, P. M., Francisco-Rodríguez-Landa, J., Cueto-Escobedo, J., & Rosales-Sánchez, O. (2026). Anticonvulsant Activity of Naringenin in Wistar Rats: Reduction in Inflammation Biomarkers. Applied Sciences, 16(10), 5057. https://doi.org/10.3390/app16105057
Vancouver
Zamora-Bello I, Rivadeneyra-Domínguez E, Saldaña-Hoyos PM, Francisco-Rodríguez-Landa J, Cueto-Escobedo J, Rosales-Sánchez O. Anticonvulsant Activity of Naringenin in Wistar Rats: Reduction in Inflammation Biomarkers. Applied Sciences. 2026;16(10):5057. doi:10.3390/app16105057
BibTeX
@article{ZamoraBello2026,
author = {Zamora-Bello, Isaac and Rivadeneyra-Domínguez, Eduardo and Saldaña-Hoyos, Paola Meribet and Francisco-Rodríguez-Landa, Juan and Cueto-Escobedo, Jonathan and Rosales-Sánchez, Oscar},
title = {Anticonvulsant Activity of Naringenin in Wistar Rats: Reduction in Inflammation Biomarkers},
journal = {Applied Sciences},
year = {2026},
volume = {16},
number = {10},
pages = {5057},
doi = {10.3390/app16105057}
}
EUVIMED